文献速递产科母胎医学

双胎妊娠非整倍体筛查综述

Screening for aneuploidy in twins.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-10-08

双胎妊娠非整倍体筛查面临独特挑战,本综述描述可选筛查方案及其利弊,并涉及消失双胎等特殊情形。无创产前检测(cfDNA)应作为一线方案,不可行时可选择颈项透明层和/或母血清标志物筛查。

要点

  • 所有孕妇均应接受非整倍体筛查,双胎妊娠需特殊考量。
  • cfDNA筛查应作为双胎妊娠一线方案。
  • cfDNA不可行时可选颈项透明层和/或母血清标志物筛查。

核心结论

  • 双胎妊娠中任何非整倍体筛查方法的准确性均不及单胎妊娠。
  • cfDNA筛查应被视为双胎妊娠的一线筛查方案。

研究设计与样本

  • 综述,未报告检索范围与样本量。

主要发现

  • 双胎妊娠非整倍体筛查存在独特挑战,无方法达到单胎妊娠的准确性。
  • cfDNA在某些临床场景(如消失双胎)可能不可用或存在局限性。

关键数值与推荐

  • 所有孕妇均应接受非整倍体筛查。
  • cfDNA不可行时,可提供颈项透明层和/或母血清标志物筛查。

临床怎么用

  • 双胎妊娠优先考虑cfDNA筛查,并告知其准确性低于单胎。
  • cfDNA不可用或存在局限时,改用颈项透明层和/或母血清标志物筛查。

局限性

  • 综述未报告检索策略、纳入研究数量及具体筛查性能数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

All pregnant women should be offered screening for aneuploidy. Twin pregnancies present unique challenges in aneuploidy screening. This review describes available aneuploidy screening options and their benefits and limitations in twin pregnancy, along with describing special circumstances, such as vanishing twins and diagnostic testing in twin pregnancy. No method of aneuploidy screening is as accurate in twin pregnancies as singleton pregnancies. Cell-free DNA screening should be considered a first-line approach; however, this option may not be available or may have limitations in certain clinical scenarios, such as vanishing twins. If cell-free DNA screening is not available, nuchal translucency and/or maternal serum marker screening can be offered.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Hopkins MK, Dugoff L. Screening for aneuploidy in twins. Am J Obstet Gynecol MFM. 2021. PMID: 34634497. doi:10.1016/j.ajogmf.2021.100499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。